Journals of Gerontology Series A: Biological Sciences and Medical Sciences Large Type Edition
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abbatecola, A. M.
Right arrow Articles by Paolisso, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abbatecola, A. M.
Right arrow Articles by Paolisso, G.
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 60:1278-1282 (2005)
© 2005 The Gerontological Society of America

Insulin Resistance and Muscle Strength in Older Persons

Angela M. Abbatecola1, Luigi Ferrucci2,3, GianPaolo Ceda4, Cosimo R. Russo2, Fulvio Lauretani2, Stefania Bandinelli2, Michelangela Barbieri1, Giorgio Valenti4 and Giuseppe Paolisso1,

1 Department of Geriatric Medicine and Metabolic Diseases II, University of Naples, Italy.
2 Laboratory of Clinical Epidemiology, Istituto Nazionale Riposo e Cura Anziani (INRCA), Geriatrics Department, Florence, Italy.
3 Longitudinal Studies Section, National Institute on Aging, Baltimore, Maryland.
4 Geriatrics Department, University of Parma, Italy.

Address correspondence to Giuseppe Paolisso, MD, Department of Geriatric Medicine and Metabolic Diseases, VI Divisione di Medicina Interna, Piazza Miraglia 2, I-80138 Napoli, Italy. E-mail:giuseppe.paolisso{at}unina2.it


    Abstract
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
Background. The functional consequences of an age-related insulin resistance (IR) state on muscle functioning are unknown. Because insulin is needed for adequate muscle function, an age-related insulin-resistant state may also be a determining factor. We evaluated the relationship between IR and handgrip muscle strength in men and women from a large population-based study (n = 968).

Methods. The degree of IR was evaluated by the homeostasis model assessment (HOMA) and muscle strength was assessed using handgrip.

Results. Simple sex-stratified correlations demonstrated that, in men, body mass index-adjusted handgrip strength correlated positively with physical activity (r = 0.321; p <.001), muscle area (r = 0.420; p <.001), muscle density (r = 0.263; p =.001), plasma albumin (r = 0.156; p =.001), insulin-like growth factor-1 (r = 0.258; p <.001), calcium (r = 0.140; p =.006), and testosterone (r = 0.325; p <.001) concentrations, whereas a negative association was found for age (r = –0.659; p <.001) and myoglobin plasma levels (r = –0.164; p =.001). In women, body mass index-adjusted handgrip strength correlated positively with physical activity (r = 0.280; p <.001), muscle area (r = 0.306; p <.001), muscle density (r = 0.341; p =.001), plasma albumin (r = 0.140; p =.001), and insulin-like growth factor-1 (r = 0.300; p <.001), whereas a negative association was found for age (r = –0.563; p <.001), myoglobin levels (r = –0.164; p =.001), and IR (r = –0.130; p =.04).

Conclusions. Sex-stratified analyses adjusted for multiple confounders showed that the relationship between IR and handgrip strength was found significant in women, whereas it was negligible and not significant in men.


THE mechanisms and etiology responsible for age-related decline in muscle functioning are complex. A decline in muscle strength, a common phenomenon observed over the aging process, is attributable both to atrophy of the skeletal muscle mass fibers and to qualitative changes in muscle tissue that reduce the magnitude of generated force (1–4). However, the underlying mechanisms responsible for the age-associated muscle mass and function decline are still unknown. Several hypotheses have been proposed, such as: a) intrinsic biochemical and physical changes (1); b) reduced neuronal stimulation due to reduction in the number of {alpha}-motoneurons or their activity (5); c) oxidative damage of DNA (6); d) mitochondrial DNA mutations in muscle tissue (7); and e) influence of external factors such as nutrition, disuse, and disease typically observed in older persons (1,8).

It is interesting that there is growing evidence that age-related changes of hormonal regulation play an important role in most of the pathophysiologic mechanisms described above and, therefore, may be implicated in the pathogenesis of age-related impairment of muscle strength (9,10). In particular, insulin may also be an important determinant of muscle function, as glucose uptake is necessary for adequate muscle contraction. Another important role played by insulin is its ability to repress whole-body proteolysis, thus shifting total-body metabolism towards an anabolic state (11,12). Age-related insulin resistance (IR) has been shown to contribute to impaired glucose handling in elderly persons (13). Therefore, it is plausible that IR may be a determinant of poor muscle strength in older persons. Furthermore, a reduction of insulin peripheral activity may reduce the muscle tissue anabolic rate leading to a relative catabolic state and, in turn, contributing to the impairment in muscle functioning. Therefore, using data from a population-based study performed in Tuscany (Italy), we tested the hypothesis that IR is associated with reduced skeletal muscle strength in older men and women.


    METHODS
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
Participants
This study is part of the InCHIANTI Study, a prospective population-based study of older persons designed by the staff at the Laboratory of Clinical Epidemiology of the Italian National Research Council of Aging, (INRCA, Florence, Italy) and carried out in the Chianti geographic area of Tuscany, Italy. The InCHIANTI Study, which has been described in detail elsewhere (14) was performed in a representative sample of the Italian population. In brief, 1453 participants (age range 20–104 years, 91% of the eligible population) were selected from the residents in the two municipalities of Greve in Chianti and Bagno a Ripoli (14). Data collection started in September 1998 and was completed in March 2000.

Our study population consisted of 968 participants between 22 and 104 years of age, selected from the cohort from Greve and Bagno a Ripoli, excluding those affected by diabetes (diagnosed according to the criteria of the American Diabetes Association) (15) or alcoholism, participants who were taking drugs known to interfere with muscle strength, and those who were affected by symptomatic osteoarthritis. All participants undergoing any pharmaceutical treatment were categorized into: drug intakers (participants currently in drug therapy) and not drug intakers (participants not undergoing any drug therapy). All participants gave their informed consent before participating in the study, which was approved by the ethical committee of our institution.

Anthropometric Determinations
Weight and height were measured using standard techniques. Body mass index (BMI) was calculated as weight (in kilograms) divided by height (in meters) squared. The waist circumference was measured at the midpoint between the lower rib margin and the iliac crest (normally umbilical level) and hip circumference at the level of the trochanters.

Metabolic Determinations and Analytical Methods
Blood samples were collected in the morning after the participants had been fasting for at least 8 hours. Using data on fasting glucose and insulin, we calculated the degree of IR according to the homeostasis model assessment (HOMA), which is a good index for assessing IR across a wide range of values and has a good correlation with insulin-mediated glucose uptake calculated by the euglycemic glucose clamp (16,17).

Baseline blood pressure was recorded by using a standard mercury sphygmomanometer. Three measurements were performed with the participant in supine position, and the average of the last two measures was used in the analysis.

Blood samples for the assay of insulin were collected in EDTA tubes, and the plasma was immediately aliquotted and stored at –80°C until assayed. Plasma insulin level was determined with a commercial double-antibody, solid-phase radioimmunoassay (intra-assay coefficient of variation = 3.1 + 0.3%; Sorin Biomedica, Milan, Italy). Cross-reactivity with human proinsulin was 0.3%.

Serum glucose level was determined by using an enzymatic colorimetric assay (Roche Diagnostics, Mannheim, Germany) and a Roche-Hitachi 917 analyzer. Commercial enzymatic tests were used for determining serum total- and high-density lipoprotein (HDL) cholesterol and triglyceride (Roche Diagnostics, Mannheim, Germany) levels. Serum low density lipoprotein (LDL) cholesterol levels were calculated by the Friedewald formula (18). Total plasma insulin-like growth factor-1 (IGF-1) concentrations (Diagnostic System Laboratories, Milan, Italy) were determined by radioimmunoassay.

Serum albumin concentration was measured with an agarose electrophoretic technique (Hydragel Protein(E) 15/30; Sebia, Issy-les-Moulineaux, France). Plasma total testosterone level was assayed using commercial radioimmunologic kits (Diagnostic Systems Laboratories, Los Angeles, CA). Myoglobin was measured by sandwich enzyme-linked immunosorbent assay (ELISA) immunoassay using an anti-myoglobin monoclonal antibody and an anti-myoglobin polyclonal antibody (Roche Diagnostics).

Physical Activity
A modified version of the European Prospective Investigation into Cancer and Nutrition (EPIC) physical activity questionnaire was given to participants. This questionnaire has been validated with objective measures of energy expenditure in a large epidemiological study (19). All participants were asked to describe their physical activity over the past year. Their responses were combined to estimate their level of physical activity into 7 categories ranging from 1 (bedridden) to 7 (high intense physical activity).

Handgrip Muscle Strength
Isometric grip strength was assessed using a handheld dynamometer (Nicholas Manual Muscle Tester, model BK-5474; Fred Sammons, Burr Ridge, IL) following a standardized measurement protocol that has been shown to provide highly reliable data (20). Handgrip strength has a good predictive validity for disability (21) and mortality (22). In our study, handgrip was a good proxy measure of global muscle strength, as it significantly correlated with other muscle groups with correlation coefficients ranging from r = 0.65 with ankle flexion to 0.72 (hip adduction).

Muscle Area and Density
A lower leg peripheral quantitative computerized tomography (pQCT) was performed in all participants using a recent generation device (XCT 2000; Stratec, Pforzheim, Germany) to evaluate calf muscle cross-sectional area. Data were derived from standard 2.5-mm-thick transverse scans obtained at 66% of the tibia length. The cross-sectional images obtained from the scans were analyzed using BonAlyse software (Jyvaskyla, Finland). Different tissues in the analysis were separated according to diverse density thresholds. The average density of muscle tissue was also calculated and used in the analysis.

Osteoarthritis
Osteoarthritis was assessed using the Western Ontario McMaster Osteoarthritis (WOMAC) index (23).

Calculation and Statistical Analysis
All analyses were performed separately in men and women. Descriptive results of continuous variables' values are presented as means ± standard deviation or as means ± standard error. To approximate normal distributions, log-transformed values for plasma insulin concentration and degree of IR (HOMA) were used in the analysis and back-transformed for data presentation in Tables 1 and 2. Associations among variables were tested with Pearson product-moment correlations. The analysis of variance test was used to evaluate the differences in clinical and metabolic characteristics between men and women. To test the correlation between handgrip muscle strength and HOMA, mean scores were calculated according to IR tertiles and compared using analysis of variance-based tests for trend. To verify whether a certain degree of IR (HOMA) was significantly associated with handgrip muscle strength, we categorized participants into two categories of IR: high degree when the measure was >2 standard deviations above the mean, or low degree of IR (HOMA) when the measure was below that of the high degree definition (such dichotomous variable was then used as an independent variable in multiple linear regression models).


View this table:
[in this window]
[in a new window]
 
Table 1. Characteristics of Study Population (N = 968).

 

View this table:
[in this window]
[in a new window]
 
Table 2. Clinical and Metabolic Characteristics Across IR Tertiles in Women (N = 500).

 
Multivariate linear regression models were used to analyze the independent association of multiple confounders with BMI-adjusted handgrip muscle strength as dependent variable. BMI-adjusted handgrip strength was performed separately in men and women. Total plasma testosterone concentrations were added to the multivariate model fitted in men. Statistical analyses were performed using the SPSS software package (Chicago, IL).


    RESULTS
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
The characteristics of the study population are reported in Table 1. Simple correlations demonstrated that, in all participants (n = 968), BMI-adjusted handgrip muscle strength correlated positively with physical activity (r = 0.405; p <.001), muscle area (r = 0.589; p <.001), muscle density (r = 0.263; p <.001), plasma albumin (r = 0.249; p =.001), and IGF-1 (r = 0.317; p <.001) concentrations, whereas a negative association was found for age (r = –0.510; p <.001) and IR (r = –0.131; p =.030).

In men, BMI-adjusted handgrip strength correlated positively with physical activity (r = 0.321; p <.001), muscle area (r = 0.420; p <.001), muscle density (r = 0.263; p =.001), plasma albumin (r = 0.156; p =.001), IGF-1 (r = 0.258; p <.001), calcium (r = 0.140; p =.006), and testosterone (r = 0.325; p <.001) concentrations, whereas a negative association was found for age (r = –0.659; p <.001) and myoglobin plasma concentrations (r = –0.164; p =.001). No significant correlation was found between BMI-adjusted handgrip strength and IR (r = 0.018; p =.719).

In women, BMI-adjusted handgrip strength correlated positively with physical activity (r = 0.280; p <.001), muscle area (r = 0.306; p <.001), muscle density (r = 0.341; p =.001), plasma albumin (r = 0.140; p =.001), and IGF-1 (r = 0.300; p <.001) concentrations, whereas a negative association was found for age (r = –0.563; p <.001), myoglobin plasma concentrations (r = –0.164; p =.001), and IR (HOMA) (r = –0.140; p =.02).

BMI-adjusted average values of handgrip muscle strength were calculated according to IR tertiles in women. There was a progressive and significant decline in muscle strength across IR tertiles (Table 2).

The relationship between a high versus low degree of IR and BMI-adjusted handgrip muscle strength independent of age, sex, waist–hip ratio, mean arterial blood pressure, drug intake, level of physical activity, and plasma levels of albumin, myoglobin, and calcium was tested in a linear multiple regression model. In a model fitted on all participants, age, sex, high versus low degree of IR, muscle area, and physical activity were independent determinants of handgrip muscle strength. In sex-stratified multivariate analyses, we found that, in women, high versus low degree of IR, age, and muscle area were independently associated with BMI-adjusted handgrip muscle strength (Table 3). In a model restricted to men, only age, physical activity, testosterone levels, and muscle area were independently associated with BMI-adjusted handgrip muscle strength (Table 3).


View this table:
[in this window]
[in a new window]
 
Table 3. Multivariate Linear Regression Model Predicting BMI-Adjusted Handgrip Muscle Strength According to Insulin Resistance, After Adjusting for Potential Confounders.

 

    DISCUSSION
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
Using data from a representative sample of the general population, we demonstrated that an elevated degree of IR is associated with poor muscle strength. In sex-stratified analyses adjusted for confounders, the relationship between IR and handgrip strength was evident and statistically significant in women, whereas it was negligible and not significant in men.

There is growing evidence that age-related changes of hormonal regulation play a role in pathophysiological mechanisms implicated in the pathogenesis of age-related muscle functioning decline (9,10). Insulin is known to play a pivotal role in muscle functioning by increasing glucose uptake and promoting intracellular glucose metabolism (24). The contraction of type I fibers is more dependent on glucose entry and metabolism than is the contraction of type IIa (fast twitch, oxidative, glycolytic) or IIb (fast twitch, glycolytic) fibers (25). Type I fibers are more responsive to insulin, larger in women, and more represented in the muscle of older persons (26). In accordance with these data, Krivickas and colleagues (27) suggested that, in elderly women, impaired muscle function results from an age-related decline of maximal unloaded shortening velocity of type I fibers. This is consistent with our findings and provides a feasible explanation as to why IR is independently associated with muscle strength in women, but not in men.

Two mechanisms may explain how IR negatively affects muscle strength weakening. First, age-related IR is associated with impaired muscle glucose handling which impairs intracellular energy production and results in weaker muscle contraction. Second, a vicious circle connects insulin action and an age-related decline in physical activity (28), which progressively aggravates the degree of IR. Lazarus and colleagues (29) have also hypothesized that IR may be a result, rather than the cause, of impaired muscle strength in elderly men. Such hypothesis is based on the evidence that handgrip muscle strength was an independent determinant of fasting insulin levels in men. For reasons that remain unclear, we failed to confirm their findings.

In addition, some reports (4,13) have underlined that the aging process is significantly associated with both reduced muscle strength and IR. Many studies have suggested that weaker muscle strength is in large part attributable to an age-related reduction of muscle mass (2,28,29–31). In both sexes, muscle mass reaches its maximum between the second and third decade of life. However, peak muscle mass is higher in men than in women (2). Because handgrip muscle strength is considered to be an essential component in the frailty syndrome and frailty has been observed to be more common among women, the female sex could confer an intrinsic risk, considering that women have lower lean mass and strength than do age-matched men (32). It has also been observed that women may have a greater vulnerability to frailty on sarcopenia than men may have (32). We specifically tested the association between IR and midlife handgrip strength, because handgrip strength has been recognized as an important marker of functional capacity in old age (21). Moreover, in women with type 2 diabetes mellitus a more prevalent decline in muscle strength was found compared to men (33). Considering that IR is involved in the pathogenesis of type 2 diabetes mellitus, a worsening degree of IR could have a more negative effect on muscle strength in older women.

During the aging process, changes both in the contractile efficiency of muscle fibers and in tissue quality, such as pericellular fat infiltration, may also contribute to altered muscle function (34,35). Moreover, IR could be further worsened by the occurrence of pericellular fat accumulation both directly and through the increased production of pro-inflammatory cytokines (36). An increased proteolytic state, commonly observed in older persons, reflects a significant depletion in protein activity and has been reported to be associated with risk factors related to muscle strength and function, such as impaired mobility and balance, suggesting a link with sarcopenia (32). It is well known that insulin is capable of preventing protein breakdown by increasing amino acid availability needed for protein synthesis in muscle tissue (13). Therefore, age-related IR may define protein catabolism and muscle weakness. Furthermore, a decline in aged skeletal muscle force might also be due to a reduction of L-type calcium channels (37). Insulin has a stimulatory effect on intracellular calcium uptake (37), thus IR may negatively affect muscle contraction through this mechanism.

Recent findings have shown that low plasma IGF-1 levels have been associated with an age-related decline in muscle mass (38) and strength (39,40). In our study, we found a positive correlation between handgrip muscle strength and IGF-1, but such a relationship was no longer statistically significant after adjusting for multiple confounders.

It should be underlined that a potential limitation of our study could be in the use of the HOMA. Unquestionably, HOMA is less precise than the glucose clamp, but HOMA has a strong correlation with the euglycemic glucose clamp method in populations with a large age range (16).

Conclusion
Many studies have suggested that age-associated muscle strength impairment is multifactorial (1–5, 26). Our findings suggest that one of these critical factors results from metabolic changes that occur during the aging process. More studies will need to verify the role of IR on specific muscle tissue and functioning in aged individuals. Indeed, our data highlight a possible role of an IR state on determining skeletal muscle weakening in older women.


    Footnotes
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
Decision Editor: John E. Morley, MB, BCh

Received June 30, 2004

Accepted September 8, 2004


    References
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 

  1. Carmeli E, Coleman R, Reznick AZ. The biochemistry of aging muscle. Exp Gerontol. 2002;37:477-489.[Medline]
  2. Evans W. Functional and metabolic consequences of sarcopenia. J Nutr. 1997;127:998S-1003S.
  3. Harris T. Muscle mass and strength: relation to function in population studies. J Nutr. 1997;127:1004S-1006S.[Medline]
  4. Iannuzzi-Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol A Biol Sci Med Sci. 2002;57A:M772-M777.[Abstract/Free Full Text]
  5. Erim Z, Beg MF, Burke DT, de Luca CJ. Effects of aging on motor-unit control properties. Am Physiol Soc. 1999;82:2081-2091.
  6. Mecocci P, Fano G, Fulle S, et al. Age-dependent increases in oxidative damage to DNA, lipids and proteins in human skeletal muscle. Free Radic Biol Med. 1999;26:303-308.[Medline]
  7. McKenzie D, Bua E, McKiernan S, Cao Z, Aiken JM, Wanagat J. Mitochondrial DNA deletion mutations: a causal role in sarcopenia. Eur J Biochem. 2002;269:2010-2015.[Medline]
  8. Baumgartner R, Koehler K, Romero L, Garry P. Serum albumin is associated with skeletal muscle in elderly men and women. Am J Clin Nutr. 1996;64:552-558.[Abstract/Free Full Text]
  9. Blackman MR, Sorkin JD, Munzer T, et al. Growth hormone and sex steroid administration in healthy aged med and women: a randomized controlled trial. JAMA. 2002;288:2282-2292.[Abstract/Free Full Text]
  10. Kamel HK, Maas D, Duthie EH, Jr. Role of hormones in the pathogenesis and management of sarcopenia. Drugs Aging. 2002;19:865-877.[Medline]
  11. Fukagawa NK, Minaker KL, Rowe JW, Matthews DE, Bier DM, Young VR. Glucose and amino acid metabolism in aging man: differential effects of insulin. Metabolism. 1988;37:371-377.[Medline]
  12. Fukagawa NK, Minaker KL, Young VR, Rowe JW. Insulin dose-dependent reductions in plasma amino acids in man. Am J Physiol. 1986;250:E13-E17.
  13. Ferrannini E, Vichi S, Beck-Nielsen H, Laakso M, Paolisso G, Smith U. European Group for the study of Insulin Resistance (EGIR). Insulin action and age. Diabetes. 1996;45:947-953.[Abstract]
  14. Ferrucci L, Bandinelli S, Benvenuti E, et al. Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. J Am Geriatr Soc. 2000;48:1618-1625.[Medline]
  15. Alberi KGMM, Zimmet PZ, for the WHO Consultation. Definition, diagnosis, and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med. 1998;15:539-553.[Medline]
  16. Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23:57-63.[Abstract]
  17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.[Medline]
  18. Friedewald WT, Levy R, Fredricson DS. Estimation of serum low density lipoprotein without the use of a preparative ultracentrifuge. Clin Chem. 1972;18:499-502.[Abstract]
  19. Wareham NJ, Jakes RW, Rennie KL, et al. Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr. 2003;6:407-413.[Medline]
  20. Bandinelli S, Benvenuti E, Del Lungo I, et al. Measuring muscular strength of the lower limbs by hand-held dynamometer: a standard protocol. Aging Clin Exp Res. 1999;11:287-293.
  21. Rantenan T, Guralnik JM, Foley D, et al. Midlife hand grip strength as a predictor of old age disability. JAMA. 1999;281:558-560.[Abstract/Free Full Text]
  22. Rantenan T, Volpato S, Ferrucci L, Heikkinen E, Fried LP, Guralnik JM. Handgrip strength and cause-specific and total mortality in older disabled women: exploring the mechanism. J Am Geriatr Soc. 2003;51:636-641.[Medline]
  23. Bellamy N, (1982). The Arthritis Index [WOMAC]. In: Bellamy N. Osteoarthritis–An Evaluative Index for Clinical Trials [MSc thesis]. Hamilton, Canada: McMaster University; 215–230.
  24. Perriot LM, Kono T, Whitesell RR, et al. Glucose uptake and metabolism by cultured human skeletal muscle cells: rate-limiting steps. Am J Physiol Endocrinol Metab. 2001;281:E72-E80.[Abstract/Free Full Text]
  25. Song XM, Ryder JW, Kawano Y, Chibalin AV, Krook A, Zierath JR. Muscle fiber type specificity in insulin signal transduction. Am J Physiol. 1999;277:R1690-R1696.
  26. Staron R, Hagerman F, Hikida R, et al. Fiber type composition of the vastus lateralis muscle of young men and women. J Histochem Cytochem. 2000;48:623-629.[Abstract/Free Full Text]
  27. Krivickas LS, Suh D, Wilkins J, Hughes VA, Roubenoff R, Frontera WR. Age- and gender-related differences in maximum shortening velocity of skeletal muscle fibers. Am J Phys Med Rehabil. 2001;80:447-455.[Medline]
  28. Zamboni M, Turcato E, Santana H, et al. The relationship between body composition and physical performance in older women. J Am Geriatr Soc. 1999;47:1403-1408.[Medline]
  29. Lazarus R, Sparrow D, Weiss ST. Handgrip strength and insulin levels: cross-sectional and prospective associations in the normative aging study. Metabolism. 1997;11:1266-1269.
  30. Baumgartner RN, Waters DL, Gallagher D, Morley JE, Garry PJ. Predictors of skeletal muscle mass in elderly men and women. Mech Ageing Dev. 1999;107:123-136.[Medline]
  31. Short KR, Nair KS. Mechanisms of sarcopenia of aging. J Endocrinol Invest. 1999;22:95-105.[Medline]
  32. Fried L, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol. 2001;56:M146-M156.
  33. Lord SR, Caplan GA, Colagiuri R, Colagiuri S, Ward JA. Sensori-motor function in older persons with diabetes. Diabet Med. 1993;10:614-618.[Medline]
  34. Lexell J, Henriksson-Larsen K, Wilblad B, Siostrom M. Distribution of aging studied in whole muscle cross-sections. Muscle Nerve. 1983;6:588-595.[Medline]
  35. Madsen OR, Lauridsen UB, Hartkopp A, Sorensen OH. Muscle strength and soft tissue composition as measured by dual energy x-ray absorptiometry in women aged 18-87 years. Eur J Appl Physiol Occup Physiol. 1997;76:239-245.
  36. Abbatecola AM, Ferrucci F, Grella R, et al. Diverse effect of inflammatory markers on insulin resistance and insulin-resistance syndrome in the elderly. J Am Geriatr Soc. 2004;52:399-404.[Medline]
  37. Cappola A, Qian-Li X, Ferrucci L, Guralnik JM, Volpato S, Fried LP. Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women. J Clin Endocrinol Metab. 2003;88:2019-2025.[Abstract/Free Full Text]
  38. Paolisso G, Gambardella A, Balbi V, et al. Effects of magnesium and nifedipine infusions on insulin action, substrate oxidation and blood pressure in aged hypertensive patients. Am J Hypertens. 1993;6:920-926.[Medline]
  39. Grounds MD. Reasons for the degeneration of ageing skeletal muscle: a central role for IGF-1 signalling. Biogerontology. 2002;3:19-24.[Medline]
  40. Barbieri M, Ferrrucci L, Emilia R, et al. Chronic inflammation and the effect of IGF-1 on muscle strength and power in older persons. Am J Physiol Metab. 2003;284:E481-E487.



This article has been cited by other articles:


Home page
Arch Intern MedHome page
A. M. Abbatecola, L. Ferrucci, R. Marfella, and G. Paolisso
Insulin Resistance and Cognitive Decline May Be Common Soil for Frailty Syndrome
Arch Intern Med, October 22, 2007; 167(19): 2145 - 2146.
[Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Maggio, F. Lauretani, G. P. Ceda, S. Bandinelli, S. Basaria, G. Paolisso, A. Ble, J. M. Egan, E. J. Metter, A. M. Abbatecola, et al.
Association of hormonal dysregulation with metabolic syndrome in older women: data from the InCHIANTI study
Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E353 - E358.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abbatecola, A. M.
Right arrow Articles by Paolisso, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abbatecola, A. M.
Right arrow Articles by Paolisso, G.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
All GSA journals The Gerontologist
Journals of Gerontology Series B: Psychological Sciences and Social Sciences